Nobelist Hoffmann To Host Chemistry Series For PBS

Although it’s certainly lively enough, it’s not “The Cosby Show.” And while it’s about science, it’s not as grandiose as “Cosmos,” the $30 million astronomy extravaganza hosted by Carl Sagan a few years ago. But for Nobel laureate Roald Hoffmann, “The World of Chemistry,” a 26-segment television series produced for the Public Broadcasting System, is a vehicle that’s sufficiently entertaining and stylish to convey his enthusia

Written byGeorge Kauffman
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Although it’s certainly lively enough, it’s not “The Cosby Show.” And while it’s about science, it’s not as grandiose as “Cosmos,” the $30 million astronomy extravaganza hosted by Carl Sagan a few years ago.

But for Nobel laureate Roald Hoffmann, “The World of Chemistry,” a 26-segment television series produced for the Public Broadcasting System, is a vehicle that’s sufficiently entertaining and stylish to convey his enthusiasm for science to a broad audience.

Geared toward a lay audience, including degree-seeking nonscience majors at two-year junior colleges, the series is expected to draw about 500,000 viewers when it airs in late 1990. Of those viewers, Hoffmann says, only a very small fraction will be students taking the course for credit. Instead, he anticipates that a far greater number or viewers will be members of the general public, people interested in learning more about the world around them (see interview with Hoffmann on ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies